Junction Therapeutics Competitors and Similar CompaniesClear all

Junction Therapeutics's competitors and similar companies include Gyre Therapeutics, Samabriva, Idogen and Siolta Therapeutics.
Junction Therapeutics
Junction Therapeutics
Junction Therapeutics is a company delivering treatments across the blood brain barrier.
Gyre Therapeutics
Gyre Therapeutics
Gyre Therapeutics (formerly known as Catalyst Biosciences) is a drug R&D company creating catalytic biopharmaceutical products based on engineered human proteases.
Samabriva
Samabriva
Samabriva is a biotechnology company specializing in the development of biotherapeutics.
Idogen
Idogen
Idogen is a biotechnology company that develops tolerogenic cell therapies.
Siolta Therapeutics
Siolta Therapeutics
Siolta Therapeutics is a biotech company focused on developing therapeutic microbial consortia to prevent and treat inflammatory disease.
Founding Date
Founding Date
N/A
Founding Date
2003
Founding Date
2011
Founding Date
2008
Founding Date
2016
Type
Type
Private
Type
Public
Type
Private
Type
Public
Type
Private
Tags
Locations
Locations
HQ
Locations
South San Francisco, US HQ
Locations
Amiens, FR HQ
Locations
Lund, SE HQ
Locations
San Francisco, US HQ
San Carlos, US
Employees
Employees
N/A
Employees
3462% increase
Employees
19
Employees
10
Employees
16
Valuation ($)
Valuation ($)
N/A
Valuation ($)
19.4 m
Valuation ($)
N/A
Valuation ($)
1.2 m
Valuation ($)
N/A

Financial

Revenue (est.)
Revenue (est.)
N/A
Revenue (est.)
$116.6m (FY, 2025)
Revenue (est.)
N/A
Revenue (est.)
N/A
Revenue (est.)
N/A
Cost of goods
Cost of goods
N/A
Cost of goods
$5.4m (FY, 2025)
Cost of goods
N/A
Cost of goods
N/A
Cost of goods
N/A
Gross profit
Gross profit
N/A
Gross profit
$111.2m (FY, 2025)
Gross profit
N/A
Gross profit
kr272k (FY, 2022)
Gross profit
N/A
Net income
Net income
N/A
Net income
$9.9m (FY, 2025)
Net income
N/A
Net income
(kr47.8m) (FY, 2022)
Net income
N/A

Funding

Total funding raised
Total funding raised
N/A
Total funding raised
$ 30m
Total funding raised
N/A
Total funding raised
N/A
Total funding raised
$ 30m
For sources of this data, please see the company profile

View Company Profiles

Gyre Therapeutics
HQ
South San Francisco, US
Employees
34

Gyre Therapeutics (formerly known as Catalyst Biosciences) is a drug R&D company creating catalytic biopharmaceutical products based on engineered human proteases.

View company
Samabriva
HQ
Amiens, FR
Employees
19

Samabriva is a biotechnology company specializing in the development of biotherapeutics.

View company
Idogen
HQ
Lund, SE
Employees
10

Idogen is a biotechnology company that develops tolerogenic cell therapies.

View company
Siolta Therapeutics
HQ
San Francisco, US
Employees
16

Siolta Therapeutics is a biotech company focused on developing therapeutic microbial consortia to prevent and treat inflammatory disease.

View company